{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:09:03Z","timestamp":1780106943472,"version":"3.54.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T00:00:00Z","timestamp":1525996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.gore.2018.05.008","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T10:46:41Z","timestamp":1526381201000},"page":"35-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Myasthenia as a paraneoplastic manifestation of ovarian Cancer"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9022-415X","authenticated-orcid":false,"given":"Marcelo","family":"Simonsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Minamoto","family":"Miyabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helio Toshio","family":"Ouki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio Cezar Ribeiro","family":"Galv\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara Alencar Rolim","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Martins","family":"Laginha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Samora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gore.2018.05.008_bb0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10072-009-0154-3","article-title":"Cerebellar degeneration and ocular myasthenia gravis in a patient with recurring ovarian carcinoma","volume":"31","author":"Caliandro","year":"2010","journal-title":"Neurol. Sci."},{"issue":"5","key":"10.1016\/j.gore.2018.05.008_bb0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1548-5315(11)70395-3","article-title":"Update on paraneoplastic neurologic disorders","volume":"7","author":"Dalmau","year":"2010","journal-title":"Commun. Oncol."},{"issue":"3","key":"10.1016\/j.gore.2018.05.008_bb0015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archneurol.2009.341","article-title":"Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers","volume":"67","author":"Giometto","year":"2010","journal-title":"Arch. Neurol."},{"issue":"8","key":"10.1016\/j.gore.2018.05.008_bb0020","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.gore.2018.05.008_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N. England J. Med."},{"issue":"9","key":"10.1016\/j.gore.2018.05.008_bb0025","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4065\/mcp.2010.0099","article-title":"Paraneoplastic syndromes: an approach to diagnosis and treatment","volume":"85","author":"Pelosof","year":"2010","journal-title":"Mayo Clin. Proc."},{"issue":"3","key":"10.1016\/j.gore.2018.05.008_bb0030","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/01.md.0000076004.64510.ce","article-title":"Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer","volume":"82","author":"Rojas-Marcos","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.gore.2018.05.008_bb0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/NRL.0b013e3181870aa2","article-title":"Paraneoplastic neurological syndromes: a review","volume":"15","author":"Toothaker","year":"2009","journal-title":"Neurologist"},{"issue":"1","key":"10.1016\/j.gore.2018.05.008_bb0045","first-page":"76","article-title":"Cisplatin-induced myasthenic syndrome","volume":"1","author":"Wright","year":"1982","journal-title":"Clin. Pharm."},{"issue":"1","key":"10.1016\/j.gore.2018.05.008_bb0050","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00432-014-1745-9","article-title":"Paraneoplastic neurological syndromes associated with ovarian tumors","volume":"141","author":"Zaborowski","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.gore.2018.05.008_bb0055","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/jnnp-2011-301237","article-title":"Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition","volume":"83","author":"Zuliani","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"updated-by":[{"DOI":"10.1016\/j.gore.2021.100703","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000}}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578918300444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578918300444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:54:45Z","timestamp":1762480485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578918300444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":11,"alternative-id":["S2352578918300444"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2018.05.008","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myasthenia as a paraneoplastic manifestation of ovarian Cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2018.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}